New antibiotic tested against superbugs in chinese hospitals

NCT ID NCT07268560

Recruiting now Disease control Sponsor: Sir Run Run Shaw Hospital Source: ClinicalTrials.gov ↗

First seen Dec 08, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This study looks at how well a new antibiotic combination, Aztreonam-Avibactam, works for hospitalized adults in China with hard-to-treat bacterial infections. About 100 patients from 30 hospitals will be observed to see if the drug clears the infection and improves recovery. The goal is to gather real-world data to help doctors use this new treatment more effectively.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA ( VAP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sir Run Run Shaw Hospital
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 310016, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The First Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

COMPLICATED INTRA-ABDOMINAL INFECTIONS, CIAIS HOSPITAL-ACQUIRED PNEUMONIA (HAP) VENTILATOR ASSOCIATED PNEUMONIA ( VAP)